Daplusiran
Daplusiran is a small interfering RNA (siRNA) component of JNJ-3989. JNJ-3989 consists of two siRNAs, Daplusiran and Tomligisiran, which target and degrade hepatitis B virus (HBV) mRNA, thereby inhibiting HBV replication.
Product Specifications
CAS Number
2202783-35-3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog